Evidence map›Paper›PMID 42418062›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026

Stenotrophomonas mexicanensis subsp. fluminensis subsp. nov., a new subspecies isolated from a clinical sample at a hospital in Rio de Janeiro, Brazil, during COVID-19 pandemic.

Juliana Nunes Ramos, Paula Araújo de Souza, Luciana Veloso da Costa, Raphael Paiva Paschoal da Silva, Maria Helena Simões Villas Bôas, Marcelo Luiz Lima Brandão

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Juliana Nunes Ramos *Institute of Technology in Immunobiologicals, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. juliana.ramos@bio.fiocruz.br.ORCID http://orcid.org/0000-0002-7063-6720
Paula Araújo de Souza *Institute of Technology in Immunobiologicals, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Luciana Veloso da CostaInstitute of Technology in Immunobiologicals, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Raphael Paiva Paschoal da SilvaGaleão Air Force Hospital, Brazilian Air Force, Rio de Janeiro, Brazil.
Maria Helena Simões Villas BôasNational Institute of Quality Control in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Marcelo Luiz Lima BrandãoInstitute of Technology in Immunobiologicals, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Funding

CAPES Finance Code 001CNPq 304877/2024-7CNPq 407747/2021-4Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/200.546/2025Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.616/2024
6 · The paper itself

Abstract

The genus Stenotrophomonas exhibits wide genetic diversity, and the Stenotrophomonas maltophilia complex (Smc) is formed by multiple cryptic species. In this study, we performed taxonomic characterization of SM006 strain, isolated from lung tissue of an 83-year-old female patient at a hospital in Rio de Janeiro. Initially identified as S. maltophilia by Matrix-Assisted Laser Desorption/Ionization - Time of Flight Mass Spectrometry and 16 S rRNA gene sequencing, the strain was phylogenetically positioned within Smc. Multilocus sequence typing identified a novel allelic profile, leading to the assignment of a new ST-1401 and a new rST (316636). Genomic analysis revealed the presence of resistance genes related to β-lactam, aminoglycoside, and RND family efflux systems, as well as an intact prophage region, indicating evolutionary interaction with phage elements. The Average Nucleotide Identity (96.51%) and digital DNA-DNA hybridization (71.90%) values were close to the limits established for species delimitation, suggesting that SM006 strain belongs to a new subspecies of the recently described Stenotrophomonas mexicanensis. Phylogenomic analyses based on core genes and orthologous proteins confirmed its grouping consistent with S. mexicanensis, but with sufficient divergence to justify its proposal as a new subspecies. Thus, the name Stenotrophomonas mexicanensis subsp. fluminensis subsp. nov. was proposed, with SM006 (= CBAS 932ᵀ = CBP P7452ᵀ) as the type strain. The phenotypic description, including growth characteristics, biochemical results, and antimicrobial susceptibility profile, reinforces its taxonomic distinction. The study highlights the central role of genomic taxonomy in the accurate identification of new taxa and in expanding knowledge about the diversity of the genus Stenotrophomonas.

Indexed as

COVID-19Gram-Negative Bacterial InfectionsStenotrophomonasAnti-Bacterial AgentsBrazilDNA, BacterialFemaleHospitalsHumansMultilocus Sequence TypingPhylogenyRNA, Ribosomal, 16SAnti-Bacterial AgentsDNA, BacterialRNA, Ribosomal, 16S16S rRNAGenomic taxonomyMLSTStenotrophomonasStenotrophomonas mexicanensis

Identifiers

PMID42418062
PMCPMC13346390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.